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Simultaneous diagnosis of severe 
imported Plasmodium falciparum malaria 
and HIV: report of three cases
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Abstract 
The increasing number of travellers to and from areas where considerable overlap between high malaria transmis-
sion and elevated prevalence of human immunodeficiency virus (HIV) infection exists, augment the probability that 
returning travellers to non-endemic countries might present with both infections. The presence of such co-infection 
can increase the severity of malaria episodes and also can change the progression of HIV infection. This article 
describes three travellers returning from malaria-endemic areas that had simultaneous diagnosis of severe Plas-
modium falciparum malaria and HIV infection. Despite the severe forms of malaria and HIV co-infection, all patients 
responded successfully to anti-malarial treatment. Malaria and HIV interact with one another, with HIV infection 
increasing parasite burden, clinical severity and risk of complications of malaria; malaria seems to create an immu-
nological interaction favourable to HIV spread and replication, with impact in progression to AIDS. The presence of 
malaria and HIV co-infection also poses other challenges related to treatment response, level of care and possible 
interactions of drugs. The authors recommend that all patients with fever returning from malaria endemic areas 
should be screened both for malaria and HIV infection.
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Background
Every year about 25–30 million individuals travel from 
Europe to areas with malaria transmission [1] and around 
25,000 cases of malaria occur, most of them having an 
uncomplicated course [2]. However rare, cases of severe 
imported malaria do occur and constitute a challenge 
for caregivers in non-endemic countries. Considerable 
overlap exist in geographical distribution of malaria and 
human immunodeficiency virus (HIV) infections [3] 
and the interaction between the two diseases raises new 
questions in the management of such patients, both in 
endemic and non-endemic countries. While the asso-
ciation between HIV infection and more severe clinical 
forms of malaria is well established in endemic countries 
[4–6], in non-endemic countries the importance of this 
interaction is largely unknown.
In particular, Portugal maintains firm relations with 
Portuguese-speaking African countries that are not only 
one of the most common destinations of Portuguese trav-
ellers and migrants but also the most common countries 
of origin of migrants entering in Portugal. These coun-
tries, namely Angola and Mozambique, are representa-
tive of the previously mentioned geographic overlap of 
malaria transmission and high prevalence of HIV infec-
tion, so with increasing numbers of people travelling to 
and from this destinations and with longer periods of 
stay, it is expected that some cases of severe malaria and 
HIV infection can be diagnosed simultaneously. Giving 
the considerable overlap of symptoms of both diseases in 
acute phase, high index of suspicion will be necessary to 
diagnose both conditions. The authors report three cases 
of severe imported Plasmodium falciparum malaria and 
HIV infection diagnosed simultaneously.
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Case presentations
Case report 1
A 24-year-old woman from Angola presented at a Uni-
versity tertiary care hospital in Porto with a three-day 
history of fever, nausea, vomiting and diarrhoea. She 
had travelled from Angola, where she lived her entire 
life, to Portugal 9  days before. Her past medical his-
tory was unremarkable. On examination, she was febrile 
(38.4°C) and tachycardic (112 bpm), blood pressure and 
peripheral oxygen saturation were both normal. Labora-
tory data revealed leucocytosis (12.48 × 109/L), slightly 
increased C-reactive protein (7.2 mg/dL), haemoglobin 
within normal range, normal platelet count, unaltered 
creatinine and normal transaminases and bilirubin. 
A thin blood film revealed the presence of P. falcipa-
rum with 4% parasitaemia. A 4th generation HIV test 
was also performed and had a doubtful result. Despite 
absence of severity criteria, the patient was admitted 
to infectious diseases (ID) ward for surveillance, treat-
ment and further investigation of a probable HIV infec-
tion. She was started on oral quinine and doxycycline. 
In the following day, the patient presented altered men-
tal status and blurred speech, without focal neurologi-
cal deficits. A brain CT scan showed diffuse cerebral 
oedema and the thin blood film revealed a reduction in 
parasitaemia to 0.3%. Repeated 4th generation HIV test 
was positive. She was admitted to infectious diseases 
intensive care unit (ID ICU) and initiated intravenous 
treatment for malaria with quinine and clindamycin 
and anti-oedema therapy with mannitol. During her 
stay in ID ICU thrombocytopenia, altered coagulation 
tests and hyperbilirubinemia appeared. Clinical evolu-
tion was favourable and the patient was transferred to 
ID ward 4 days after admission in ID ICU. Complimen-
tary study confirmed HIV infection with a viral load of 
433,000 copies/mL and a T CD4  +  lymphocyte count 
of 550 cells/mm3. She was discharged 12  days after 
admission and was referred to HIV clinic for follow-up 
(Table 1).
Case report 2
A 41-year-old man from Portugal presented to the emer-
gency room of a hospital with a 2-day history of fever 
and headache. He had been working in Angola in the last 
3 years and had returned to Portugal 3 weeks before the 
beginning of symptoms. He reported a previous episode 
of malaria diagnosed in Angola treated with artemisinin 
derivatives. On examination he was febrile (39°C) and 
jaundice was apparent. Laboratory data revealed normal 
haemoglobin, thrombocytopenia (21  ×  109 platelets/L), 
leukopenia (2.8 × 109/L) and elevated bilirubin (4.7 mg/
dL). A thin blood smear revealed the presence of Plasmo-
dium, but parasitaemia and species identification were 
not done. He was transferred to a University tertiary care 
hospital and was admitted to ID ICU. A repeated thin 
blood film showed a P. falciparum parasitaemia of 54%. 
A rapid diagnostic test was also performed and was posi-
tive for P. falciparum infection. Intravenous therapy with 
quinine and doxycycline was promptly initiated. On his 
5th day at ID ICU and despite steady decrease in para-
sitaemia, the patient developed acute respiratory failure 
and shock, needing norepinephrine support and inva-
sive mechanical ventilation. In the following day, the 
result of a 4th generation HIV test performed earlier was 
available and was positive. During his stay in ID ICU the 
patient also had avascular femoral head necrosis and a 
coagulase-negative Staphylococcus bacteraemia. Compli-
mentary workup for HIV infection revealed a viral load 
of 855,084 copies/mL and T CD4  +  lymphocyte count 
of 196 cells/mm3. After prolonged and difficult ventila-
tor weaning, the patient was transferred to ID ward at his 
37th day in hospital.
In the ID ward, the evolution was favourable and a 
repeated T CD4  +  lymphocyte count performed after 
acute infections resolved revealed 188 cells/mm3. He 
started opportunistic infection prophylaxis with cotri-
moxazole and after 44 days in the hospital, antiretroviral 
therapy with efavirenz and tenofovir/emtricitabine was 
initiated. He was discharged 47 days after admission and 
Table 1 Patients’ characteristics
Patient 1 Patient 2 Patient 3
Age (years) 24 41 47
Sex Female Male Male
Length of ICU stay (days) 4 37 5
Country of Malaria transmission Angola Angola Mozambique
P. falciparum parasitaemia 4% 54% 1%
HIV viral load (copies/mL) 433,000 copies/mL 855,084 copies/mL 199,802 copies/mL
T CD4 + lymphocytes count/mm3 550 196 302
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was referred to HIV and Travel Medicine clinics because 
he had the intention to return to Angola.
Case report 3
A 47-year-old man from Portugal presented to the emer-
gency room of a hospital in the same day of his return 
from Mozambique, where he had been working dur-
ing the previous year, with diarrhoea, vomiting and 
abdominal pain with less than 24  h of evolution. He 
was prescribed domperidone and paracetamol and was 
discharged home. The symptoms persisted and a week 
later he also noticed the appearance of fever, jaundice 
and apathy. He went to the emergency room of another 
hospital 9  days after return. On examination jaundice 
and dehydration were apparent and he had normal heart 
rate and blood pressure. During is stay in emergency 
room he had a generalized tonic–clonic seizure. Labora-
tory data revealed anemia (9.9 g/dL), thrombocytopenia 
(17  ×  109 platelets/L), elevated bilirubin (10.0  mg/dL), 
elevated serum creatinine (7.76  mg/dL) and hypona-
tremia (127  mEq/L). A thin blood smear revealed the 
presence of Plasmodium, but species identification and 
parasitaemia were not done. He was transferred to a Uni-
versity tertiary care hospital and admitted to ID ICU. A 
repeated thin blood film revealed a P. falciparum parasi-
taemia of 1%. Intravenous therapy with quinine and dox-
ycycline was initiated. At admission a 4th generation HIV 
test was also positive. He needed continuous venovenous 
haemodiafiltration during 4 days and then he was put on 
intermittent haemodialysis. At the 4th day in ICU parasi-
taemia was negative and in 5th day after admission qui-
nine and doxycycline were switched to oral route and the 
patient was discharged to ID ward. In the ward he had 
good evolution and progressive recovery of kidney func-
tion was noticed. Complimentary workup for HIV infec-
tion revealed a viral load of 199,802 copies/mL and T 
CD4 + lymphocyte count of 302 cells/mm3. He was dis-
charged home 10 days after admission and was referred 
to HIV clinic.
Discussion
These three different patients illustrate several aspects of 
the malaria-HIV interaction. These two infections inter-
act bidirectionally and synergistically with each other, so 
HIV can increase the severity of malaria, risk of adverse 
events and parasite burden while malaria can potentially 
accelerate HIV disease progression. All of the patients, 
without previously known HIV infection, experienced 
severe forms of P. falciparum malaria. Several reports 
from endemic countries show an increased prevalence 
and severity of clinical malaria in HIV infected patients 
[4, 6, 7]. However, these effects seem to depend from age, 
degree of immunosuppression and previous immunity to 
malaria [6]. Indeed, studies from endemic countries show 
increased prevalence of parasitaemia, clinical malaria 
and higher parasite density, increasing with the severity 
of immunosuppression, in adults with naturally acquired 
immunity to malaria [4, 6, 8]. Although the described 
interaction is extensively documented in endemic coun-
tries, in non-endemic countries data available about 
imported malaria and HIV co-infection is scarce. How-
ever, a study from Mouala et  al. [9] in France revealed 
that, whatever the severity criteria used for malaria, HIV-
infected patients with immunosuppression were at signif-
icantly higher risk of developing severe malaria than the 
non-HIV infected patients.
In case reports 1 and 3, the authors describe two 
patients with severe forms of malaria and HIV infection 
without advanced immunosuppression. The interaction 
between these two infections may explain to some extent 
malaria severity even in a previous immune adult (patient 
1) and despite the absence of advanced immunosuppres-
sion. Conversely, in case report 2 the patient had some 
degree of malaria immunity but immunosuppression was 
present. HIV-infected patients with immunosuppression 
may present with higher parasite burden [6, 10] and this 
might explain the unusually high parasitaemia found in 
patient 2. Indeed the control of malaria parasitaemia is 
immune mediated and the immune deficiency caused 
by HIV infection can reduce the immune response to 
malaria parasitaemia and, therefore, increased parasite 
burden and frequency of clinical attacks of malaria are 
expected [8, 10]. Despite immunosuppression and very 
high parasitaemia, this patient had a favourable outcome 
probably as result of a relatively rapid initial diagnosis, 
early treatment and high-level supportive care provided 
in ICU. The importance of supportive care was describe 
in a report by Cohen et  al. [11] that analysed patients 
treated in a tertiary care setting with ICU and dialysis. All 
three patients had relatively high HIV viral load, which 
can be related with malaria co-infection because malaria 
is associated with a strong CD4 + lymphocyte activation 
and up-regulation of pro-inflammatory cytokines, pro-
viding an ideal microenvironment for the spread of HIV 
among CD4 + cells and thus for a rapid replication that 
clinically can be seen by the increased HIV viral loads. 
All patients responded well to malaria treatment, despite 
that in Portugal the intravenous forms of artemisinin 
derivatives are unavailable. However, there is evidence 
of a possible impaired response to anti-malarials in HIV-
patients, particularly those with immunosuppression [6].
Patient 2 intended to return to Angola as soon as pos-
sible. Clinical malaria is more frequent in HIV-infected 
patients, so the probability of repeat episodes of clini-
cal malaria is high and this raises the question about 
potential interactions between antiretroviral therapy and 
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anti-malarials [10]. Pharmacological interactions between 
these two classes of drugs are well documented in vitro, 
with the majority of them involving the cytochrome 
P450 [5]. Nonetheless, the importance of these interac-
tions in clinical grounds is uncertain and specific guide-
lines for treatment of malaria in HIV-infected patients 
under antiretroviral treatment are lacking. Patient 2 initi-
ated therapy with efavirenz and tenofovir/emtricitabine, 
a choice that may raise some important questions in 
a patient willing to return to an endemic area. Accord-
ing to World Health Organization recommendations, 
first line treatment for malaria in endemic areas should 
include an artemisinin derivative combined with lume-
fantrine, amodiaquine, sulfadoxine-pyrimethamine or 
piperaquine. Some reports document the potential inter-
action of efavirenz with a combination of artesunate and 
amodiaquine, resulting in increased transaminases and 
amodiaquine concentrations [6]. These reports led some 
authors to contraindicate amodiaquine containing regi-
mens in patients under efavirenz [6]. The patient was also 
under prophylaxis with cotrimoxazole, which is an effec-
tive measure in reducing clinical malaria in HIV-infected 
patients but may raise concerns about development of 
resistance to antifolate anti-malarial drugs [4, 12].
Considerable overlap exists between symptoms of 
malaria, acute HIV infection and other opportunistic 
infections related to HIV, with the cardinal symptom of 
all those situations being fever. The traveller or migrant 
presenting in a non-endemic country with fever repre-
sents a clinical challenge and it is important that all cli-
nicians recognise that malaria and HIV may co-exist and 
influence the clinical course of each other. Also early rec-
ognition of HIV co-infection in patients with malaria is 
important because the possible higher severity warrants 
more intense monitoring and a lower threshold for addi-
tional investigations to diagnose possible concomitant 
infections [13].
Considering the continuous movement of persons to 
and from endemic areas of malaria and with high prev-
alence of HIV, the authors recommend that all patients 
with fever returning from malaria endemic areas should 
be screened both for malaria and HIV infection.
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